Immune Checkpoint Inhibitor Efficacy in BRAF-Mutant NSCLC Immune Checkpoint Inhibitor Efficacy in BRAF-Mutant NSCLC

Various immune checkpoint inhibitors are used in the treatment of non-small cell lung cancer, but how effective are they in patients with BRAF mutations?Translational Lung Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news